A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials

By Filippi M   Rovaris M   Capra R   Gasperini C   Yousry TA   Sormani MP   Prandini F   Horsfield MA   Martinelli V   Bastianello S   Kühne I   Pozzilli C   Comi G  

Brain, Vol. 121, Iss. 10, 1998-10 ,pp. : 2011-2020

Oxford University Press

Access to resources Recommend Favorite

Magnetic Resonance Techniques in Clinical Trials in Multiple Sclerosis.

By Halpin S.  

Brain, Vol. 123, Iss. 5, 2000-05 ,pp. : 1066-1067

Oxford University Press

Access to resources Recommend Favorite

The natural history of multiple sclerosis: a geographically based study. 6. Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis

By Cottrell DA   Kremenchutzky M   Rice GPA   Hader W   Baskerville J   Ebers GC  

Brain, Vol. 122, Iss. 4, 1999-04 ,pp. : 641-647

Oxford University Press

Access to resources Recommend Favorite

Spanish centre for rehabilitation of multiple sclerosis to be built

By Bosch X.  

Lancet Neurology, Vol. 2, Iss. 7, 2003-07 ,pp. : 391-391

Elsevier

Access to resources Recommend Favorite

The clinical and pathological dynamics of multiple sclerosis

By McDonald W.I.  

Electroencephalography and Clinical Neurophysiology/ Electromyography and Motor Control, Vol. 97, Iss. 4, 1995-09 ,pp. : 4-5

Elsevier

Access to resources Recommend Favorite